Home›Stock Screener›Vaidya Sane Ayurved Laboratories›Financial Statements

Vaidya Sane Ayurved Laboratories Complete Financial Statements

5 Years of Data
2026 - 2022

In FY2023, Vaidya Sane Ayurved Laboratories (MADHAVBAUG) reported revenue ₹5,173 Cr, net profit ₹235 Cr and EPS ₹1.12, with a net profit margin of 4.5% and ROE of 270.1%. Full financial statements from FY2022 to FY2026 (5 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Examine MADHAVBAUG quarterly performance for recent quarterly revenue, profit and EPS trends.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 4.54% 2023 data
EBITDA Margin 6.42% 2023 data
Operating Margin 5.00% 2023 data
Return on Assets 223.81% 2023 data
Return on Equity 270.11% 2023 data

Balance Sheet Ratios

Current Ratio 7.33 2023 data
Equity Ratio 82.86% 2023 data
Asset Turnover 49.27 2023 data

MADHAVBAUG Revenue, Net Profit & EBITDA — Year-on-Year Growth

MADHAVBAUG YoY (Sept 2022 vs Sept 2023) — revenue -48.5%, net profit -75.7%, EBITDA -64.0%, expenses -47.0%. For live price, earnings ratios and company overview, see Vaidya Sane Ayurved Laboratori share price screener.

Revenue Growth
-48.5%
Year-over-Year
Net Profit Growth
-75.7%
Year-over-Year
EBITDA Growth
-64.0%
Year-over-Year
Expense Growth
-47.0%
Year-over-Year
Assets Growth
+36.4%
Year-over-Year
Equity Growth
+38.1%
Year-over-Year
Operating Cash Flow Growth
+1200.0%
Year-over-Year
Investing Cash Flow Growth
+23.1%
Year-over-Year
Financing Cash Flow Growth
-106.7%
Year-over-Year

MADHAVBAUG Income Statement — Revenue, EBITDA & Net Profit

Vaidya Sane Ayurved Laboratories revenue ₹5,173 Cr, EBITDA ₹332 Cr, net profit ₹235 Cr, EPS ₹1.12 (2023) — net profit margin 4.5%. Analyse Vaidya Sane Ayurved Laboratori ownership structure to track promoter, FII and institutional holdings.

Periods ₹ Crores
Particulars Sept 2023 Jun 2023 Sept 2022
Revenue 5,173 4,641 10,053
Expenses 4,842 4,142 9,131
EBITDA 332 500 922
Operating Profit Margin % 5.00% 9.00% 8.00%
Depreciation 159 116 260
Interest 16 11 19
Profit Before Tax 157 373 643
Tax -78 126 -323
Net Profit 235 247 967
Earnings Per Share (₹) 1.12 2.60 4.60

MADHAVBAUG Balance Sheet — Assets, Liabilities & Shareholders' Equity

MADHAVBAUG total assets ₹105 Cr, total equity ₹87 Cr, total liabilities ₹ Cr (2026) — ROE 270.1%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023
ASSETS
Total Assets 105 77 70 55
Current Assets 44 30 31 28
Fixed Assets 37 34 28 21
Capital Work in Progress 2 1 3 2
Investments 4 15 16 14
Other Assets 0 27 23 19
LIABILITIES
Total Liabilities
Current Liabilities 6 3 3 2
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 87 63 56 41
Share Capital 11 11 11 11
Reserves & Surplus 77 52 32 30

MADHAVBAUG Cash Flow Statement — Operating, Investing & Financing

Vaidya Sane Ayurved Laboratories operating cash flow ₹11 Cr, investing ₹-10 Cr, financing ₹-1 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023
Operating Activities 11 -1 0
Investing Activities -10 -13 1
Financing Activities -1 15 -1
Net Cash Flow 0 1 -1